Newsletter | April 30, 2026

04.30.26 -- Validating Candel's BLA-Ready Analytics Profile

SPONSOR

At TIDES USA 2026, experts discuss how formulation science, stability strategies, and advanced analytics help reduce CMC risk and enable confident development of peptide and nucleic acid therapeutics.

FOCUS ON OUTSOURCING

Validating Candel's BLA-Ready Analytics Profile

The adenovirus/prodrug company discusses in-house assay development and the validation work to confirm CQAs like potency and cell line integrity.

The Future Of CGT: Integrating Digitalization With Regulatory Readiness

Explore how manufacturers scale from batch-of-one to commercial supply while maintaining compliance. Learn strategies to strengthen quality and digital efficiency for modern therapy production.

When To Consider Material And Personnel Airlocks For Downflow Booths

Strategic use of airlocks in downflow booth design enhances pressure stability and containment. A risk-based approach ensures facility integration meets rigorous safety and compliance standards.

Robotics And AI In Pharma: Driving The Next Wave Of Innovation

Adopting AI and robotics enhance sterility and regulatory compliance and enable real-time decision-making and reduce human-borne contamination, ensuring the safe production of complex therapies.

Defining Raw Materials, Starting Materials, Drug Substance And Drug Product

Manufacturing complexity often blurs the lines between raw materials and drug products. This guide clarifies definitions for process intermediates to ensure consistency across the workflow.

Automated DNA Size Selection For Flexible NGS Workflow Integration

Learn how automating DNA size selection improves fragment recovery and consistency. Optimized bead ratios and programmable handling increase throughput while maintaining high-quality results.

Model-Driven Genetic Design For Bioprocess Optimization

Traditional biomanufacturing relies too heavily on trial and error. By integrating AI and mechanistic models into early design, developers can overcome productivity limits and accelerate timelines.

How GMP And Clinical Rules Shape Upstream Discovery And Development

Early collaboration between R&D and manufacturing ensures regulatory readiness and efficiency. Watch how automation and robust panel design enable clinical translation for advanced cell therapy development.

Mycoplasma Detection: A Critical Defense For Ensuring Biopharmaceutical Quality

Discover how integrated PCR-based workflows provide the specificity and speed necessary to safeguard your cell matrix and ensure regulatory compliance.

SPONSOR

The 2026 ISPE AI in Life Sciences Summit

The 2026 ISPE AI in Life Sciences Summit – Powered by GAMP® will be held 22–23 June in Boston, offering insight into how AI is advancing within the life sciences sector. Sessions explore model governance, data integrity, explainability, and inspection ready design. Attendees gain practical frameworks for integrating AI into GxP workflows and guidance on how to meet evolving regulatory expectations. LEARN MORE

OUTSOURCING SOLUTIONS

Automated, Single-Use Systems For TFF At Multiple Scales - Cytiva

Excellence For Cell And Gene Therapy Manufacturing - Roche CustomBiotech

Connect With Cell & Gene: